Vitamin B12 Deficiency: Why the Standard Test Can Lull You into a False Sense of Security
There is no asterisk on your lab report, nothing is flagged. Your feet tingle anyway. Why total B12 often raises the alarm late, and which markers can look earlier.
A normal B12 result is reassuring. Often rightly so. But sometimes too soon. The standard test shows how much B12 is circulating in your blood. It does not show whether it arrives in your nerve cells.
I bet you know this scene. You're sitting in the doctor's office, the results are on the desk. B12 normal, iron fine, thyroid unremarkable. All good, you're told.
Except it doesn't feel good. In the evening your feet tingle, as if ants were crawling under your skin. The stairs in the dark feel less steady than they used to. And sometimes, in the middle of a sentence, a word that was always there is suddenly missing.
Maybe you told yourself: stress. Age. Imagination. I'd like to show you another possibility. Not as a diagnosis, but as a question worth asking.
This article complements our piece Measuring vitamin B12 deficiency the right way, which explains the lab tests step by step. Here we look at the questions before and after. Why is it the standard value, of all things, that so easily lulls you into feeling safe? And what can an undetected deficiency do to your nerves, mood and defenses in the meantime?
What to expect in this article
- Why total B12 tends to raise the alarm late
- How Holo-TC and methylmalonic acid can look earlier
- Three traps in which the standard value points the wrong way
- What a silent deficiency can do to nerves, mood and defenses
- Who should take a closer look, and why time matters
- Three levers for your next doctor's appointment
Tingling with a normal result
I know this pattern very well. Imagine a woman in her mid-fifties who spends much of her working day at a desk. For years she has been taking tablets for heartburn.
Her total B12 was indeed in the lower normal range, with no flag. When Holo-TC and methylmalonic acid were measured as well, a different picture emerged. The active fraction was low, and methylmalonic acid was elevated. That fits a functional deficiency, meaning B12 that is missing inside the cells.
The turning point was not a new supplement. It was the question of why. In a joint discussion with her family doctor, the acid blockers came up as a possible cause. The treatment was carried out under medical supervision.
The lesson: a normal value is a snapshot of transport. It is not a report card for your nerves.
Account balance and spending power: why normal doesn't mean well supplied
Picture your bank statement. At the top there's a reassuring total. What it doesn't say: a large part of it is tied up in a savings account you can't touch. At the supermarket checkout, only what's available in your checking account counts.
B12 in your blood works in much the same way. It travels there on two different proteins. One is called haptocorrin. It's a storage protein, so more like the savings account. The other is called transcobalamin. Only the B12 bound to transcobalamin can be taken up by your body's cells through a dedicated receptor. This part is called holotranscobalamin, Holo-TC for short, or active B12.
The standard lab value measures both together. It shows you the balance, not the spending power.
Ebba Nexo and Elke Hoffmann-Lücke of Aarhus University Hospital summarized in 2011 what is known about active B12.
Only about a quarter of the B12 in the blood is bound to transcobalamin and therefore available to the cells. Comparative studies suggest that Holo-TC detects a deficiency better than total B12.
What this means for you: roughly three quarters of your measured value say little about what your cells are receiving right now.
Nexo E, Hoffmann-Lücke E. Am J Clin Nutr. 2011;94(1):359S-365S. DOI: 10.3945/ajcn.111.013458The second reason is time. A B12 deficiency rarely develops overnight. It progresses in stages, and the standard value tends to stand near the back of the line.
Serum depletion
When no more B12 comes in, the transporter transcobalamin empties first. Holo-TC falls.
Holo-TC responds earlyCell depletion
The reserves in the cells and on the storage protein decline. From the outside, you usually notice nothing yet.
Total B12 often still in the normal rangeMetabolic deficiency
The enzymes get too little B12. Methylmalonic acid and homocysteine rise, and the production of new DNA slows down.
MMA and homocysteine respondClinical deficiency
Now anemia or nerve symptoms appear. The nerves can even react before the blood count does.
Total B12 often abnormal only lateIn 1994, V. Herbert of Mount Sinai Medical Center in New York described four stages a person goes through when no more B12 comes in.
First the transporter empties, according to Herbert just a few days after absorption stops. That is why Holo-TC drops below the normal range long before total B12 does. The total value mainly reflects the B12 bound to the storage protein.
What this means for you: the standard value is more of a latecomer. By the time it raises the alarm, the deficiency has often been underway for a while.
Herbert V. Am J Clin Nutr. 1994;59(5 Suppl):1213S-1222S. DOI: 10.1093/ajcn/59.5.1213SSounds like theory? There are measurements that show exactly this pattern.
In 2005, Wolfgang Herrmann and his team at Saarland University Hospital in Homburg examined omnivores, vegetarians, older adults and dialysis patients.
They found elevated methylmalonic acid together with low Holo-TC even at total B12 levels of up to 300 pmol/L. That is a range many labs report as normal. Their conclusion: Holo-TC predicts B12 status considerably better than the total value.
What this means for you: an unremarkable total value does not reliably rule out a deficiency inside the cell. The authors also stress, however, that Holo-TC and methylmalonic acid are harder to interpret when kidney function is impaired.
Herrmann W, Obeid R, Schorr H, Geisel J. Curr Drug Metab. 2005;6(1):47-53. DOI: 10.2174/1389200052997384A team led by Lindenbaum at Columbia-Presbyterian Medical Center in New York examined 548 older adults from the Framingham Study.
Alongside B12, they measured the metabolic markers methylmalonic acid and homocysteine. Their conclusion: at least 12 percent had a B12 deficiency. Many older people with normal serum levels were undersupplied with B12 or folate at the metabolic level.
What this means for you: normal on paper and sufficient in the cell are two different statements.
Lindenbaum J, Rosenberg IH, Wilson PW et al. Am J Clin Nutr. 1994;60(1):2-11. DOI: 10.1093/ajcn/60.1.2The usual question is: Is my B12 normal? The more helpful question is: Is B12 arriving where I need it?
A single value answers the first question. The second sometimes takes more than one number.
And now you know why a normal total value can be good news, but not the final word.
A late marker with a gray zone: what studies show about the standard value
Maybe you're thinking: labs have cutoffs, surely they must mean something. They do. It's just that with B12, the line is less sharp than a missing asterisk would suggest.
Routine labs usually measure total B12. It's inexpensive, quick and available everywhere. As a first orientation, that makes sense. The following figures show what a broader view can add.
A team led by Valente studied 700 people aged 63 to 97. The reference standard for a true deficiency was the B12 in red blood cells.
Holo-TC reached an area under the curve of 0.90. That is a measure of accuracy, where 1.0 would be perfect. Total B12 came in at 0.80, methylmalonic acid at 0.78. With total B12, 45 percent of results landed in an unclear zone, with Holo-TC only 14 percent.
What this means for you: Holo-TC can give more people a clear answer. For context: the first author worked for a manufacturer of laboratory tests.
Valente E, Scott JM, Ueland PM et al. Clin Chem. 2011;57(6):856-863. DOI: 10.1373/clinchem.2010.158154Lawrence Solomon of Yale University reviewed the records of 456 people who had been evaluated for B12 deficiency as outpatients.
Of 95 evaluable people, 37 responded to B12 in their blood count or nerves. Before treatment, 54 percent of them had a normal B12 value, 23 percent normal methylmalonic acid and 50 percent normal homocysteine. On top of that, all three values fluctuated by up to 23 percent within two to six weeks.
What this means for you: no single value decides on its own. A limitation: this was a chart review without a control group, and a response can have other causes too.
Solomon LR. Blood. 2005;105(3):978-985. DOI: 10.1182/blood-2004-04-1641The cutoff itself is also shifting. The 2024 British guideline NICE NG239 considers deficiency likely when total B12 is below 180 ng/L. Between 180 and 350 ng/L, it speaks of an indeterminate range. If your value falls there and you have symptoms, an additional marker such as methylmalonic acid can bring clarity.
In 2026, a team led by Pelloso at Padua University Hospital analyzed the laboratory data of 5,147 adults.
The lower total B12 was, the higher homocysteine rose, on average from 15.9 to 21.5 to 34.9 µmol/L. According to the authors, values between 258 and 341 ng/L could indicate early depletion that deserves confirmation.
What this means for you: even values that are not flagged on your report can be a clue. However, the figures apply to one specific manufacturer's test method.
Pelloso M, Cesana BM, Musso G et al. Clin Chem Lab Med. 2026;64(5):1117-1123. DOI: 10.1515/cclm-2025-1722Then there is a point that rarely gets mentioned. Different manufacturers' assays don't deliver the same numbers.
In 2025, an international team led by Cesana at the University of Milan compared the common B12 assays using 1,791 external quality assessment measurements and 97 serum samples.
Some methods measured systematically higher, others lower than the comparison method. The authors conclude that the recommended thresholds should not simply be applied to all tests.
What this means for you: the same blood sample can produce a somewhat different number depending on the lab. Ideally, compare your values within the same lab.
Cesana BM, da Molin S, Jassam N et al. Clin Chem Lab Med. 2025;63(12):2433-2441. DOI: 10.1515/cclm-2025-0939Things look somewhat better for Holo-TC. A recent review from Rome concluded in 2026 that Holo-TC can offer advantages in selected situations. One reason: most Holo-TC tests are referenced to a common WHO standard. That improves comparability between labs.
Holo-TC and methylmalonic acid are not oracles either. When kidney function is impaired, methylmalonic acid in particular becomes harder to interpret, and according to some data Holo-TC does too. To this day, there is no single gold standard. According to a major review, the exact cutoffs remain debated.
That is why a team led by Fedosov developed a combined index called cB12. It combines total B12, Holo-TC, methylmalonic acid and homocysteine into a single number. Values below minus 0.5 point to a deficiency. The idea behind it is simple: several witnesses are more reliable than one.
A lab value is a witness, not a judge. A single witness can be wrong, especially one who arrives late.
Only when symptoms, risk factors and several markers point in the same direction does a picture emerge that you can trust.
And now you know why, when someone has symptoms, I rarely stop at a single number.
Three traps in which the standard value points the wrong way
Sometimes the value isn't just late. Sometimes it simply points the wrong way. That sounds unsettling. Above all, it's good to know, because each of these traps can be recognized.
Falsely reassuring
- You're already taking B12 from the drugstore. The value rises before the cause has been clarified.
- Antibodies against intrinsic factor can interfere with some test methods.
- Nitrous oxide can put the brakes on B12 while the blood value looks unremarkable.
High doesn't mean well supplied
- A high value without supplementation can be a sign of another condition.
- Supplements or antibody complexes can also raise the value.
- Even a high total value says nothing on its own about what reaches the cells.
Low doesn't automatically mean deficiency
- The combined pill can lower the total value without a deficiency being present.
- In pregnancy, active B12 is considered the more accurate first test.
- Different assays deliver different numbers.
The first trap is the most treacherous, because it reassures you. One piece of the puzzle is intrinsic factor. This is a protein from the stomach lining without which B12 is barely absorbed in the gut. If the immune system forms antibodies against it, this can disrupt not only absorption but also the measurement.
In 2023, a team at Hôpital Européen Georges Pompidou in Paris described a 48-year-old woman with anemia whose B12 value came back normal every time it was measured.
Elevated homocysteine and elevated methylmalonic acid did not fit. The explanation: very high levels of antibodies against intrinsic factor were interfering with the test. A different assay showed a markedly low B12 level.
What this means for you: if a normal value doesn't fit your symptoms, it is fair to question the measurement itself. It is a single case, but it describes an interference mechanism that labs can check for when there is a suspicion.
Ghammad W, Sarthou A, Dutkiewicz M et al. Ann Biol Clin (Paris). 2023. DOI: 10.1684/abc.2023.1834Nitrous oxide can be similarly deceptive. It circulates as a party drug in balloons, but it is also used in medicine. Nitrous oxide can chemically inactivate B12 without the blood value always dropping clearly.
In 2019, a team led by Oussalah at the University of Lorraine in Nancy analyzed data from 100 people in 85 publications who had fallen ill after exposure to nitrous oxide.
Eighty percent had abnormal sensations such as tingling. A B12 value below 150 pmol/L was found in 70.7 percent, whereas elevated methylmalonic acid was found in 93.8 percent.
What this means for you: with nitrous oxide, functional markers reveal the deficiency more reliably than the blood value alone. If you have used nitrous oxide and notice tingling, you should mention it openly to your doctor.
Oussalah A, Julien M, Levy J et al. J Clin Med. 2019;8(4):551. DOI: 10.3390/jcm8040551And then there is the opposite case. A high B12 value looks like a top grade. But without supplementation, it can be a signal that deserves attention.
A Danish team led by Arendt at Aarhus University Hospital linked the B12 values of 333,667 people to the national registries. Anyone who received B12 as treatment was not counted.
The higher the value, the more often cancer was detected afterwards, especially in the first year. At values above 800 pmol/L, the standardized incidence ratio was 6.27.
What this means for you: the researchers interpret high B12 as a marker, not a cause. An unexplained high value without supplementation should be assessed by a doctor rather than filed away as a top grade.
Arendt JF, Pedersen L, Nexo E, Sørensen HT. J Natl Cancer Inst. 2013;105(23):1799-1805. DOI: 10.1093/jnci/djt315A recent review also lists supplements and complexes of antibodies and B12 among the causes of high values. So high is not automatically good, and not automatically dangerous. High needs an explanation.
That leaves the third trap, the false alarm. The NICE guideline urges cautious interpretation if you take the combined pill or are already taking over-the-counter B12. In pregnancy, it prefers active B12 as the first test, because it is considered more accurate there. Hormones can change the transport proteins and with them the number, not necessarily your supply.
Your B12 value is not a thermometer that only reads in one direction. Too low, too high or seemingly normal: what matters is whether the number fits you.
If it doesn't fit your symptoms, that is no reason to worry. It is a reason to ask more closely.
And now you know why, with every B12 value, I first ask what you are taking and how you are feeling.
What a silent deficiency can do to your nerves, mood and defenses
Tingling in your toes. A furry, numb feeling on the soles of your feet. A gait that becomes unsteady in the dark. A memory that snags more often. A heaviness you can't explain.
These symptoms have many possible causes. B12 is one of them, and one that can be checked. To understand why the nerves in particular react so sensitively, it's worth looking inside the cell.
There, B12 works at two workbenches. At the first, it is involved in methylation. That is the attaching of small chemical labels that cells use to regulate genes and make building blocks. The insulating layer of your nerves probably needs this process too. At the second workbench, in the mitochondrion, B12 converts an intermediate product from the breakdown of certain fatty acids and amino acids. When B12 is missing, methylmalonic acid backs up there. That is exactly why it is such a direct marker.
From the perspective of Clinical Psychoneuroimmunology, KPNI for short, B12 is therefore not just a blood topic. It touches all four systems that we look at together: nerves, immune system, metabolism and hormones.
Nervous system
Methylation and mitochondria supply the nerve sheath. If both stall, tingling, numbness and an unsteady gait can develop, often before any anemia.
Immune system
Autoimmune processes in the stomach can block B12 absorption. Conversely, studies suggest that a deficiency may alter killer cells and inflammatory messengers.
Metabolism
Without B12, methylmalonic acid and homocysteine back up. Metformin and acid blockers can slow down your supply over the years.
Hormonal system
Autoimmune thyroid diseases are more often accompanied by B12 deficiency. The pill and pregnancy can change the transport proteins and thus the number.
Nervous system: when the line crackles
Imagine your nerves as electrical cables with insulation. If the insulation gets thinner, the signal skips, crackles or arrives late. That is exactly how many people describe the tingling: as static on the line.
A team led by Healton at Columbia-Presbyterian Medical Center in New York analyzed 153 episodes of B12 deficiency with nerve involvement in 143 people.
It usually began with abnormal sensations such as tingling, or with an unsteady gait. In 27.4 percent of episodes, the proportion of red blood cells was normal, meaning there was no anemia. The longer the symptoms had lasted before treatment, the more severe they were, and the smaller the improvement.
What this means for you: your blood count can look unremarkable while your nerves have long been reacting. And time plays a role.
Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Medicine (Baltimore). 1991;70(4):229-245. DOI: 10.1097/00005792-199107000-00001Immune system: trigger and target at once
This is where it gets interesting from a KPNI perspective. With B12, the immune system can play a role twice over. It can be the cause, when it attacks the cells of the stomach lining that produce intrinsic factor. This is called autoimmune gastritis, and in its advanced stage pernicious anemia. And it can itself suffer from a deficiency.
In 2009, Scalabrino of the Institute of General Pathology at the University of Milan summarized the research on B12 and nerve tissue, mainly from experiments in rats.
With B12 deficiency, the inflammatory messenger TNF-alpha rose in the animals' spinal cord and cerebrospinal fluid. Protective factors such as EGF and interleukin-6 fell. An imbalance between TNF-alpha and EGF was also found in people with severe deficiency.
What this means for you: nerve damage from B12 deficiency could also be mediated through the immune system. In humans, this has not yet been conclusively established.
Scalabrino G. Prog Neurobiol. 2009;88(3):203-220. DOI: 10.1016/j.pneurobio.2009.04.004A team led by Tamura at Gunma University in Japan compared 11 people with B12 deficiency anemia with 13 controls.
In those with deficiency, CD8 cells were reduced and natural killer cell activity was dampened. After injections of methylcobalamin, both values improved.
What this means for you: B12 could play a role in cellular defense. The study is small and has no placebo group, so it shows a direction, not proof.
Tamura J, Kubota K, Murakami H et al. Clin Exp Immunol. 1999;116(1):28-32. DOI: 10.1046/j.1365-2249.1999.00870.xMood and brain
Your brain needs finely tuned chemistry, every single day. So it is hardly surprising that B12 also shows up in studies on mood.
A team led by Tiemeier at Erasmus MC in Rotterdam screened 3,884 older adults for depressive symptoms and compared their blood values.
B12 deficiency was associated with depressive disorders, even after accounting for cardiovascular disease and physical disability. For folate, by contrast, the association weakened considerably after this adjustment.
What this means for you: low mood has many causes, and B12 deficiency is one that can be measured. This observational study cannot reliably separate cause and effect.
Tiemeier H, van Tuijl HR, Hofman A et al. Am J Psychiatry. 2002;159(12):2099-2101. DOI: 10.1176/appi.ajp.159.12.2099Metabolism and hormones: the quiet players
In metabolism, a B12 deficiency shows up through two backlog values, methylmalonic acid and homocysteine. Elevated homocysteine can have many causes, however, including folate deficiency or kidney function. You'll find more on this in the article Elevated homocysteine.
Among the hormones, the thyroid stands out in particular. Autoimmune thyroid disease and an autoimmune reaction in the stomach occur together more often.
A team led by Ness-Abramof at Sapir Medical Center in Israel measured B12 in 115 people with autoimmune thyroid disease, such as Hashimoto's.
Among them, 28 percent had a low B12 value. In 31 percent of these, elevated gastrin pointed to pernicious anemia, meaning an autoimmune reaction against the stomach.
What this means for you: if your immune system already has your thyroid in its sights, it is worth taking a look at B12. You can read more background in the article Understanding Hashimoto's thyroiditis.
Ness-Abramof R, Nabriski DA, Braverman LE et al. Am J Med Sci. 2006;332(3):119-122. DOI: 10.1097/00000441-200609000-00004This is not about a number on paper. It is about whether you can rely on your feet, on your memory, on your mood. A well-supplied nervous system is not a luxury. It is a piece of independence.
Shukri Jarmoukli, ViveCura BerlinTingling in your feet is neither imagination nor a mandatory part of getting older. It is a signal that deserves a question.
Sometimes the answer is B12. Sometimes it is something else, such as diabetes, the thyroid or even too much vitamin B6, as we show in the article Too much vitamin B6. Either is better than guesswork.
And now you know why, with nerve symptoms, I don't just look at the blood count.
Who should take a closer look, and why time matters
Maybe someone already came to mind as you were reading. Your mother with her stomach tablets. Your colleague who has been taking metformin for years. Or yourself, since you switched to a plant-based diet.
A deficiency usually develops in one of three ways: too little intake, poorer availability or impaired absorption. This gives rise to groups for whom a second look is especially worthwhile.
Where a second look is worthwhile
- Older age. In the Framingham Study, the prevalence of B12 deficiency among older adults was at least 12 percent.
- A vegan or vegetarian diet without reliable supplementation. In a study from Homburg, 92 percent of vegans not taking vitamin supplements had low Holo-TC and 83 percent had elevated methylmalonic acid.
- Long-term acid blockers. In large datasets, proton pump inhibitors were associated with more frequent deficiency.
- Metformin over many years. The risk rose with every year of use.
- Autoimmune diseases. Especially of the thyroid or the stomach.
- Procedures and diseases of the digestive tract. For example stomach or bowel surgery, celiac disease or inflammatory bowel disease.
- Nitrous oxide. Even with recreational use, it can inactivate B12 in metabolism.
In the US Diabetes Prevention Program, 2,155 people with prediabetes were randomly assigned to metformin or placebo. A team led by Aroda later analyzed their B12 levels.
After five years, 19.1 percent of those on metformin had low or borderline low values of up to 298 pg/mL, compared with 9.5 percent on placebo. Each year of metformin use was linked to a higher risk of deficiency, with an odds ratio of 1.13 per year. Nerve damage was more common among those on metformin with low B12.
What this means for you: metformin is a valuable medication, so please don't stop it on your own. Regular B12 monitoring can make sense, though, and the authors recommend it too.
Aroda VR, Edelstein SL, Goldberg RB et al. J Clin Endocrinol Metab. 2016;101(4):1754-1761. DOI: 10.1210/jc.2015-3754There are similar data for acid blockers. In a case-control study from Kaiser Permanente in California, 25,956 people with newly diagnosed B12 deficiency were compared with 184,199 people without deficiency. Those who had received proton pump inhibitors for two years or longer had an odds ratio of 1.65. At more than 1.5 tablets a day, it was 1.95. Stomach acid is needed to release B12 from food. You'll find more on this in the article Low stomach acid.
Why time matters
Time is the factor no lab report captures. In the New York case series, a median of four months passed between the first symptoms and treatment, and for some people considerably longer. After treatment, the nerve symptoms receded fully in 47.1 percent of episodes. Lasting moderate or severe impairment remained in 6.3 percent. The longer the symptoms had lasted beforehand, the smaller the improvement.
The NICE guideline also emphasizes speed here. If a B12-related change in the blood count with nerve symptoms is suspected, treatment should not wait for pending lab results. The blood for diagnostic tests is drawn beforehand.
With B12, caution does not mean waiting until the value is clear-cut. With nerve symptoms, time itself is a finding.
That doesn't mean panic. It means: get it checked promptly instead of watching for months.
And now you know why risk factors and symptoms carry more weight for me than a single missing asterisk.
Three levers for your next doctor's appointment
I am deliberately not giving you a dose. That depends on the cause, and the cause belongs in a personal assessment. What I am giving you are three directions you can put into practice right away.
Bring your story, not just your old lab report
Write down what you have been feeling, since when, and when it gets stronger. Bring a list of all your medications and supplements. That includes acid blockers, metformin, the pill and anything from the drugstore. This list can reveal more than the number on the report.
Ask for a second look
If your total B12 is in the lower or middle range and you have symptoms, Holo-TC or methylmalonic acid can bring clarity. If your kidney function is impaired, interpretation needs particular care. How the stepwise testing works in detail is explained in the article Measuring vitamin B12 deficiency the right way.
Blood test first, supplements second, and no waiting with nerve symptoms
If you are already taking B12, you shift your values before the cause has been clarified. Tingling, numbness or an unsteady gait should be checked by a doctor promptly. There are several routes for treatment. In a Cochrane review, 1,000 to 2,000 micrograms daily as a tablet achieved similar or higher blood levels than injections, although the evidence is thin. Which route fits depends on the cause, for instance on whether absorption in the stomach is impaired.
Questions you can ask
- Was only total B12 measured, or also Holo-TC or methylmalonic acid?
- Does my value fit my symptoms and my medications?
- Was my kidney function taken into account in the interpretation?
- Had I already been taking B12 before the blood draw?
- Are there signs of an autoimmune reaction in the stomach, such as antibodies against intrinsic factor?
Well established: nerve symptoms from B12 deficiency can occur without anemia. Long-term use of metformin or acid blockers is associated with more frequent deficiency. Holo-TC performed better than total B12 in comparative studies.
Plausible, but less well supported: the role of immune messengers in nerve damage and the influence of B12 on killer cells. Here we rely on small studies and animal models.
Open: exact cutoffs, a uniform gold standard and the transferability of thresholds between labs.
A normal B12 value is good news when it fits you. If it doesn't fit what your body is telling you, it is the beginning of a question, not its end. The standard value measures transport. Your nerves need arrival.
Frequently asked questions
Can I have a deficiency despite a normal B12 value?
Yes, that's possible. The standard test measures all the B12 in your blood, including the part bound to the storage protein haptocorrin, which your cells cannot take up directly. Only about a quarter is bound to transcobalamin and therefore active. In studies, low Holo-TC and elevated methylmalonic acid were found even at total values of up to 300 pmol/L. If your symptoms don't fit the normal value, a functional marker can bring clarity.
At what B12 level should I take a closer look if I have symptoms?
There is no single number that applies to everyone, because labs measure differently. The 2024 British NICE guideline considers deficiency likely when total B12 is below 180 ng/L and calls 180 to 350 ng/L an indeterminate range. An Italian analysis of lab data already rated values between 258 and 341 ng/L as possible early depletion. If your value is in the lower or middle range and you have symptoms, an additional marker such as Holo-TC or methylmalonic acid is a sensible question to ask your doctor.
What is Holo-TC, and why is it considered an early marker?
Holo-TC stands for holotranscobalamin, meaning B12 that is bound to its transport protein transcobalamin. Only in this form can your body's cells take up B12 through a receptor, which is why it is also called active B12. If absorption stalls, this transporter empties first, according to the classic description within just a few days. That is why Holo-TC usually drops below the normal range long before total B12 does. When kidney function is impaired, interpretation is more difficult.
Why do my feet tingle even though my blood count is normal?
A B12 deficiency can affect the nerves before it changes the blood count. In a New York case series, the proportion of red blood cells was normal in 27.4 percent of episodes with nerve involvement. Tingling or an unsteady gait were often the first signs. But tingling can also have other causes, such as diabetes, the thyroid, alcohol or too much vitamin B6. That's why it should be checked by a doctor rather than put down to age.
What does a high B12 value mean if I'm not taking anything?
A high value does not automatically mean a good supply. It can result from supplements or antibody complexes, but sometimes it can also be a sign of a disease, for example of the blood-forming system. In a Danish registry study of 333,667 people, a markedly elevated value without B12 treatment was associated with a higher risk that cancer would be detected in the following year. The researchers interpret the value as a marker, not a cause. That's why an unexplained high value should be assessed by a doctor.
Can a B12 supplement distort my lab result?
Yes. If you're already taking B12, you raise your blood levels, often before the cause of a deficiency has been clarified. That's why the British NICE guideline urges cautious interpretation when over-the-counter supplements are already being taken. It also recommends drawing blood for diagnostic tests before starting treatment. But don't stop supplements prescribed by your doctor on your own. Bring it up before the test instead.
Can the pill or pregnancy change my B12 value?
Yes, hormones can change the number without your supply changing to the same extent. The combined pill can lower total B12 by altering transport proteins, and the NICE guideline advises cautious interpretation here. In pregnancy, it prefers active B12 as the first test, because it is considered more accurate there. Conversely, a genuine deficiency can also exist while you're on the pill. What matters is the overall picture of symptoms and markers.
Can a B12 deficiency affect my mood?
That's possible. In the Rotterdam Study, with 3,884 older adults screened, B12 deficiency was associated with depressive disorders, even after accounting for physical illness. An observational study like this cannot reliably separate cause and effect. Low mood has many causes. A measurable B12 deficiency is one that shouldn't be overlooked.
Does a B12 deficiency weaken the immune system?
There are indications of this, but the evidence is thin. In a small Japanese study, people with B12 deficiency had fewer CD8 cells and dampened natural killer cell activity, and both improved after methylcobalamin was given. Animal experiments also suggest that inflammatory messengers such as TNF-alpha could be involved in nerve damage caused by B12 deficiency. Large human studies are still lacking.
Can nerve damage from B12 deficiency recede?
Often yes, but not always fully. In a New York case series, nerve symptoms receded fully after treatment in 47.1 percent of episodes, while lasting moderate or severe impairment remained in 6.3 percent. The longer the symptoms had lasted beforehand, the smaller the improvement. With nerve symptoms, a prompt assessment is therefore more important than waiting for a clear-cut value.
How does this article differ from the article on B12 testing?
The article Measuring vitamin B12 deficiency the right way explains lab testing with Holo-TC, methylmalonic acid and homocysteine step by step. This article starts before and after that. It shows why the standard value, of all things, can give false reassurance, when it points the wrong way and what an undetected deficiency can do to nerves, mood and the immune system. The two texts complement each other.
Further reading in the Supplement Guide
Related articles from this guide
- Measuring vitamin B12 deficiency the right way: Holo-TC, MMA and why the serum value can be misleading
- Elevated homocysteine: causes, studies and what lowers it
- Folate instead of folic acid: what is behind MTHFR and methylation
- B vitamins: what each one does and why the complex makes sense
- Too much vitamin B6: why a vitamin, of all things, can irritate the nerves
- Micronutrient analysis: what whole blood shows and the serum value misses
- All articles in the Supplement Guide
Related topics
Supplements
Nutrients, lab tests and sensible supplementation
This articleThyroid
Autoimmunity, Hashimoto's and nutrients
Iron
Blood count, fatigue and storage values
Nutrition
Eating plant-based and staying well supplied
Sources
All studies were researched via PubMed and checked against the PubMed metadata (title, authors, year, journal, DOI), with key papers additionally checked via Consensus and Europe PMC. The study type is given in square brackets.
- Herbert V. Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr. 1994;59(5 Suppl):1213S-1222S. DOI: 10.1093/ajcn/59.5.1213S [Review, staging model]
- Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011;94(1):359S-365S. DOI: 10.3945/ajcn.111.013458 [Review]
- Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr. 2003;78(1):131-136. DOI: 10.1093/ajcn/78.1.131 [Cohort, cross-sectional comparison, n=174]
- Herrmann W, Obeid R, Schorr H, Geisel J. The usefulness of holotranscobalamin in predicting vitamin B12 status in different clinical settings. Curr Drug Metab. 2005;6(1):47-53. DOI: 10.2174/1389200052997384 [Real-world, cross-sectional study, several groups]
- Lindenbaum J, Rosenberg IH, Wilson PW, Stabler SP, Allen RH. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr. 1994;60(1):2-11. DOI: 10.1093/ajcn/60.1.2 [Cohort, Framingham Study, n=548]
- Valente E, Scott JM, Ueland PM, Cunningham C, Casey M, Molloy AM. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B12 status in the elderly. Clin Chem. 2011;57(6):856-863. DOI: 10.1373/clinchem.2010.158154 [Real-world, diagnostic cross-sectional study, n=700]
- Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood. 2005;105(3):978-985. DOI: 10.1182/blood-2004-04-1641 [Real-world, retrospective cohort, n=456]
- Pelloso M, Cesana BM, Musso G et al. Optimizing diagnostic thresholds of total vitamin B12 (B12) for identifying cobalamin deficiency in adults with macrocytic anemia. Clin Chem Lab Med. 2026;64(5):1117-1123. DOI: 10.1515/cclm-2025-1722 [Real-world, retrospective laboratory data analysis, n=5,147]
- Cesana BM, da Molin S, Jassam N et al. Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications. Clin Chem Lab Med. 2025;63(12):2433-2441. DOI: 10.1515/cclm-2025-0939 [In vitro, laboratory method comparison, 1,791 external quality assessment measurements and 97 serum samples]
- Sands T, Jawed A, Stevenson E, Smith M, Jawaid I. Vitamin B12 deficiency: NICE guideline summary. BMJ. 2024;385:q1019. DOI: 10.1136/bmj.q1019 [Consensus guideline, summary of NICE guideline NG239]
- Fedosov SN, Brito A, Miller JW, Green R, Allen LH. Combined indicator of vitamin B12 status: modification for missing biomarkers and folate status and recommendations for revised cut-points. Clin Chem Lab Med. 2015;53(8):1215-1225. DOI: 10.1515/cclm-2014-0818 [Real-world, methods study, database n=5,211]
- Green R, Allen LH, Bjørke-Monsen AL et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017;3:17040. DOI: 10.1038/nrdp.2017.40 [Review]
- Marandola M, Napoli G, Leggeri S et al. Holotranscobalamin vs Total Vitamin B12: Current Evidence and Laboratory Challenges. J Appl Lab Med. 2026. DOI: 10.1093/jalm/jfag131 [Review]
- Ghammad W, Sarthou A, Dutkiewicz M et al. Pernicious anemia with false normal vitamin B12 levels caused by intrinsic factor antibodies interference: a case report. Ann Biol Clin (Paris). 2023. DOI: 10.1684/abc.2023.1834 [Case report, original language French]
- Oussalah A, Julien M, Levy J et al. Global Burden Related to Nitrous Oxide Exposure in Medical and Recreational Settings: A Systematic Review and Individual Patient Data Meta-Analysis. J Clin Med. 2019;8(4):551. DOI: 10.3390/jcm8040551 [Systematic review, IPD meta-analysis of case reports, n=100]
- Arendt JF, Pedersen L, Nexo E, Sørensen HT. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst. 2013;105(23):1799-1805. DOI: 10.1093/jnci/djt315 [Cohort, registry-based, n=333,667]
- Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70(4):229-245. DOI: 10.1097/00005792-199107000-00001 [Case series, retrospective, 153 episodes in 143 patients]
- Scalabrino G. The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency. Prog Neurobiol. 2009;88(3):203-220. DOI: 10.1016/j.pneurobio.2009.04.004 [Mechanism review, mainly in vivo, rat]
- Tamura J, Kubota K, Murakami H et al. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol. 1999;116(1):28-32. DOI: 10.1046/j.1365-2249.1999.00870.x [Case-control with before and after measurement, n=24]
- Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM. Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry. 2002;159(12):2099-2101. DOI: 10.1176/appi.ajp.159.12.2099 [Cohort, Rotterdam Study, n=3,884 screened]
- Ness-Abramof R, Nabriski DA, Braverman LE et al. Prevalence and evaluation of B12 deficiency in patients with autoimmune thyroid disease. Am J Med Sci. 2006;332(3):119-122. DOI: 10.1097/00000441-200609000-00004 [Real-world, cross-sectional, n=115]
- Aroda VR, Edelstein SL, Goldberg RB et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-1761. DOI: 10.1210/jc.2015-3754 [RCT, secondary analysis, n=2,155]
- Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. DOI: 10.1001/jama.2013.280490 [Case-control, n=210,155]
- Wang H, Li L, Qin LL, Song Y, Vidal-Alaball J, Liu TH. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3(3):CD004655. DOI: 10.1002/14651858.CD004655.pub3 [Systematic review, 3 RCTs, n=153]